EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

Effect of an Antacid (Aluminum Hydroxide/Magnesium Hydroxide/Simethicone) or a Proton Pump Inhibitor (Omeprazole) on the Pharmacokinetics of Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) in Healthy Adult Subjects

Gina Patel, Vipul K Gupta iD, Leanne Gasink, Floni Bajraktari, Yang Lei, Akash Jain, Praveen Srivastava, Angela K Talley

Antimicrobial Agents and Chemotherapy · 2023

DOI: 10.1128/aac.01495-22 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Gina Patel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Patel Kwan Consultancy, LLC, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Antacids, Anti-Ulcer Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spero Therapeutics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tebipenem pivoxil hydrobromide (TBP-PI-HBr) is a novel oral carbapenem prodrug being developed for the treatment of serious bacterial infections. This open-label, 3-period, fixed sequence study evaluated the effect of gastric acid-reducing agents, aluminum hydroxide/magnesium hydroxide/simethicone, and omeprazole on the pharmacokinetics (PK) of tebipenem (TBP), the active moiety, following coadministration with immediate release TBP-PI-HBr during fasting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntacidsAnti-Ulcer AgentsAdultHumansAdministration, OralAluminum HydroxideCross-Over StudiesDrug InteractionsMagnesium HydroxideOmeprazoleProton Pump InhibitorsSimethiconeCarbapenems

Stichwörter der Autor:innen

aluminum hydroxide/magnesium hydroxide/simethiconedrug interactionomeprazolepharmacokineticstebipenem

Substanzen

Aluminum HydroxideAntacidsAnti-Ulcer AgentsMagnesium HydroxideOmeprazoleProton Pump InhibitorsSimethiconeL 084Carbapenems

Autor:innen und Institutionen

  • Patel Kwan Consultancy, LLC, Madison, Wisconsin, USA.
  • Spero Therapeutics, Cambridge, Massachusetts, USA.

ORCID-Profile: Vipul K Gupta

Förderung

  • Spero Therapeutics

Zitieren

APA

Patel, G., Gupta, V. K., Gasink, L., Bajraktari, F., Lei, Y., Jain, A., Srivastava, P., & Talley, A. K. (2023). Effect of an Antacid (Aluminum Hydroxide/Magnesium Hydroxide/Simethicone) or a Proton Pump Inhibitor (Omeprazole) on the Pharmacokinetics of Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) in Healthy Adult Subjects. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01495-22

Vancouver

Patel G, Gupta VK, Gasink L, Bajraktari F, Lei Y, Jain A, et al. Effect of an Antacid (Aluminum Hydroxide/Magnesium Hydroxide/Simethicone) or a Proton Pump Inhibitor (Omeprazole) on the Pharmacokinetics of Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) in Healthy Adult Subjects. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.01495-22

BibTeX
@article{Patel2023,
  author = {Patel, Gina and Gupta, Vipul K and Gasink, Leanne and Bajraktari, Floni and Lei, Yang and Jain, Akash and Srivastava, Praveen and Talley, Angela K},
  title = {Effect of an Antacid (Aluminum Hydroxide/Magnesium Hydroxide/Simethicone) or a Proton Pump Inhibitor (Omeprazole) on the Pharmacokinetics of Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) in Healthy Adult Subjects},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  doi = {10.1128/aac.01495-22}
}
Kostenlos starten →